# 2026-04973: Pharma Giant Wants to Mass-Produce Magic Mushrooms' Psilocybin

2026-04973, Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-03-13, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 12, 2026. Such persons may also file a written request for a hearing on the application on or before May 12, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-04973
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-04973
- Title: Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 12448
- Published: 2026-03-13
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 12, 2026. Such persons may also file a written request for a hearing on the application on or before May 12, 2026.
- Comments close: 2026-05-12
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Pharma Giant Wants to Mass-Produce Magic Mushrooms' Psilocybin

## Summary

Patheon API Services Inc. wants to become a big-time maker of certain controlled drugs like amphetamine and psilocybin. This move affects companies and regulators who can comment or ask for a hearing by May 12, 2026. If approved, Patheon will produce these substances in large amounts, which could impact drug availability and industry business.

## Abstract

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-04973 on federalregister.gov](https://www.federalregister.gov/documents/2026/03/13/2026-04973/bulk-manufacturer-of-controlled-substances-application-patheon-api-services-inc)
- [2026-04973 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-03-13/pdf/2026-04973.pdf)

## Related
- [Previous: 2026-04972, Importer of Controlled Substances Application: Lonza Tampa, LLC](https://policyrisk.com/federal-register/2026-04972)
- [Next: 2026-04974, Sunshine Act Meetings](https://policyrisk.com/federal-register/2026-04974)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-04973 (as of 2026-06-08).
